Form 4 for MRNA Moderna
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-02 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $136.43 | -459 | 5,243 | -8% | -$62.6K |
| D | 2023-03-03 | 2023-03-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +930 | 5,702 | +19% | $0 |
| D | 2023-03-03 | 2023-03-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -930 | 2,791 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-02 | S | D | 459 | $136.43 | 5,243 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | M | A | 930 | $0.00 | 5,702 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-01 | M | D | 930 | $0.00 | 2,791 | D | $0.00 · — to — | 930 Common Stock | (F3) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |